Jefferies Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-147
Closed -$117K 2329
2016
Q4
$117K Hold
147
﹤0.01% 1998
2016
Q3
$129K Buy
+147
New +$106K ﹤0.01% 2010
2015
Q2
Sell
-587
Closed -$918K 3297
2015
Q1
$918K Buy
+587
New +$774K 0.01% 1091

Other funds holding BLUE

Jefferies Group's BLUE Position: Q2 2021 in Review

Jefferies Group sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 463 shares — an estimated $181K sold.

Jefferies Group first reported a position in BLUE in Q1 2015 and held it in 11 quarters. The position peaked at $2.23M in Q2 2018. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Jefferies Group reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 463 bluebird bio shares in Q2 2021, an estimated $181K.
  • Jefferies Group first reported a position in bluebird bio in Q1 2015 and held it in 11 quarters.
  • Jefferies Group's bluebird bio position peaked at $2.23M in Q2 2018.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.